- Investigator
- Kethandapatti Balaji
- Ages
- 18 Years - 100 Years
- Sexes
- All
Clinical trials
-
A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC who are BCG Na簿ve/Received Incomplete BCG Treatment -
A Phase 1 Study of EG-70 as an Intravesical Administration to Patients with BCG -Unresponsive NMIBC - Investigator
- Mark G Bandyk
- Ages
- 18 Years - 101 Years
- Sexes
- All